Pfizer · Change in Working Capital

Latest reported-$1.99Bperiod endingJun 28, 2026

PFE Change in Working Capital (-$223.10M → -$1.99B)

Annual change in working capital

High-resolution chart · PNG

PFE change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Change in Working Capital — Annual fiscal periods (USD)
Period ending	Change in Working Capital (USD)
Dec 31, 2025	-5,354,000,000
Dec 31, 2024	-3,066,000,000
Dec 31, 2023	-2,172,000,000
Dec 31, 2022	-4,456,000,000
Dec 31, 2021	12,804,000,000
Dec 31, 2020	-275,000,000
Dec 31, 2019	-4,031,000,000
Dec 31, 2018	-926,000,000
Dec 31, 2017	1,296,000,000
Dec 31, 2016	85,000,000
Dec 31, 2015	564,000,000
Dec 31, 2014	1,423,000,000
Dec 31, 2013	-3,392,000,000
Dec 31, 2012	-1,942,000,000
Dec 31, 2011	2,729,000,000
Dec 31, 2010	-10,426,000,000
Dec 31, 2009	12,517,000,000
Dec 31, 2008	4,859,000,000
Dec 31, 2007	-800,000,000
Dec 31, 2006	3,016,000,000
Dec 31, 2005	-586,000,000
Dec 31, 2004	-862,000,000
Dec 31, 2003	-693,000,000
Dec 31, 2002	3,000,000
Dec 31, 2001	446,000,000
Dec 31, 2000	1,803,000,000
Dec 31, 1999	-1,261,000,000
Dec 31, 1998	224,000,000
Dec 31, 1997	-1,110,000,000
Dec 31, 1996	-381,000,000
Dec 31, 1995	-77,600,000
Dec 31, 1994	-128,600,000
Dec 31, 1993	-79,600,000
Dec 31, 1992	-370,600,000
Dec 31, 1991	-342,700,000
Dec 31, 1990	-59,400,000
Dec 31, 1989	-223,100,000